- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/08 - Clostridium, e.g. Clostridium tetani
Patent holdings for IPC class A61K 39/08
Total number of patents in this class: 864
10-year publication summary
|
81
|
50
|
62
|
68
|
78
|
67
|
30
|
28
|
34
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2361 |
49 |
| Glaxosmithkline Biologicals S.A. | 1640 |
43 |
| Revance Therapeutics, Inc. | 144 |
27 |
| MERZ PHARMA GmbH & CO. KGaA | 619 |
18 |
| The University of Tokyo | 4162 |
16 |
| Wyeth LLC | 653 |
13 |
| The Regents of the University of California | 19859 |
12 |
| University of Guelph | 356 |
12 |
| Valneva Austria GmbH | 114 |
12 |
| Pfizer Inc. | 3371 |
11 |
| Wisconsin Alumni Research Foundation | 3868 |
11 |
| The Trustees of the University of Pennsylvania | 4311 |
9 |
| Sanofi Pasteur Inc. | 356 |
8 |
| University of South Florida | 1818 |
7 |
| Zoetis Services LLC | 1539 |
7 |
| Novartis AG | 10882 |
6 |
| The Regents of the University of Michigan | 4675 |
6 |
| The Board of Regents of the University of Oklahoma | 609 |
6 |
| The Medical College of Wisconsin, Inc. | 397 |
6 |
| Sanofi Pasteur SA | 76 |
6 |
| Other owners | 579 |